These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31023057)

  • 1. Biotin interference in immunoassay: a review for the laboratory scientist.
    Avery G
    Ann Clin Biochem; 2019 Jul; 56(4):424-430. PubMed ID: 31023057
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotin interference: Underrecognized patient safety risk in laboratory testing.
    Gifford JL; Sadrzadeh SMH; Naugler C
    Can Fam Physician; 2018 May; 64(5):370. PubMed ID: 29760259
    [No Abstract]   [Full Text] [Related]  

  • 3. Depletion of biotin using streptavidin-coated microparticles: a validated solution to the problem of biotin interference in streptavidin-biotin immunoassays.
    Trambas C; Lu Z; Yen T; Sikaris K
    Ann Clin Biochem; 2018 Mar; 55(2):216-226. PubMed ID: 28406314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of biotin interference in 21 Vitros 5600 immunoassays and risk mitigation for patient safety at a large academic medical center.
    Stieglitz HM; Korpi-Steiner N
    Clin Biochem; 2020 Jan; 75():53-61. PubMed ID: 31677994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best practices in mitigating the risk of biotin interference with laboratory testing.
    Bowen R; Benavides R; Colón-Franco JM; Katzman BM; Muthukumar A; Sadrzadeh H; Straseski J; Klause U; Tran N
    Clin Biochem; 2019 Dec; 74():1-11. PubMed ID: 31473202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotin immunoassay interference: A UK-based prevalence study.
    Sanders A; Gama R; Ashby H; Mohammed P
    Ann Clin Biochem; 2021 Jan; 58(1):66-69. PubMed ID: 32936669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biotin interference within interference suppressed immunoassays.
    Kabiri P; Weiskirchen R; van Helden J
    J Clin Lab Anal; 2021 Sep; 35(9):e23940. PubMed ID: 34346119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic kidney failure and biotin: A combination inducing unusual results in thyroid and parathyroid investigations, report of 2 cases].
    Ranaivosoa MK; Ganel S; Agin A; Romain S; Parent X; Reix N
    Nephrol Ther; 2017 Dec; 13(7):553-558. PubMed ID: 29133077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitigating biotin interference in two Roche immunoassays by premixing biotinylated capturing molecules with streptavidin coated beads.
    Yang J; Wiencek JR
    Clin Chim Acta; 2020 Jun; 505():130-135. PubMed ID: 32084383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference of anti-streptavidin antibodies: More common than we thought? In relation to six confirmed cases.
    Ricci V; Esteban MP; Sand G; Menises MM
    Clin Biochem; 2021 Apr; 90():62-65. PubMed ID: 33545112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erroneous thyroid diagnosis due to over-the-counter biotin.
    Charles S; Agrawal N; Blum M
    Nutrition; 2019 Jan; 57():257-258. PubMed ID: 30199718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotin interference in immunoassays based on biotin-strept(avidin) chemistry: An emerging threat.
    Luong JHT; Male KB; Glennon JD
    Biotechnol Adv; 2019; 37(5):634-641. PubMed ID: 30872068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misdiagnosis of Graves' hyperthyroidism due to therapeutic biotin intervention.
    De Roeck Y; Philipse E; Twickler TB; Van Gaal L
    Acta Clin Belg; 2018 Oct; 73(5):372-376. PubMed ID: 29098964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences.
    Piketty ML; Polak M; Flechtner I; Gonzales-Briceño L; Souberbielle JC
    Clin Chem Lab Med; 2017 May; 55(6):780-788. PubMed ID: 27732554
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Dasgupta A; Khalil S; Paddock T; Wahed A
    Ann Clin Lab Sci; 2022 Jan; 52(1):161-163. PubMed ID: 35181630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotin interference in high-sensitivity cardiac troponin T testing: a real-world evaluation in acute cardiac care.
    Vroemen WHM; van Doorn WPTM; Kimenai DM; Wodzig WKWH; de Boer D; Bekers O; Meex SJR
    Cardiovasc Res; 2019 Dec; 115(14):1950-1951. PubMed ID: 31665256
    [No Abstract]   [Full Text] [Related]  

  • 17. Strategies for mitigating risk posed by biotin interference on clinical immunoassays.
    Gifford JL; de Koning L; Sadrzadeh SMH
    Clin Biochem; 2019 Mar; 65():61-63. PubMed ID: 30582902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferences in free thyroxine concentration using the Roche analytical platform: improvement of the third generation?
    Ruth I; Mathieu E; Burniat A; Fage D; Cotton F; Wolff F
    Clin Chem Lab Med; 2020 Jan; 58(2):e36-e39. PubMed ID: 31377735
    [No Abstract]   [Full Text] [Related]  

  • 19. Apparent Hyperthyroidism Caused by Biotin-Like Interference from IgM Anti-Streptavidin Antibodies.
    Lam L; Bagg W; Smith G; Chiu WW; Middleditch MJ; Lim JC; Kyle CV
    Thyroid; 2018 Aug; 28(8):1063-1067. PubMed ID: 29808739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotin Interference in Clinical Immunoassays: A Cause for Concern.
    Holmes EW; Samarasinghe S; Emanuele MA; Meah F
    Arch Pathol Lab Med; 2017 Nov; 141(11):1459-1460. PubMed ID: 29072950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.